Search results - 7 results
Opinion: Airtightness for Decontamination by Fumigation of High-Containment Laboratories
airtightness. Starting from a previous study in which we measured the airtightness in 4 BSL-3 laboratories with blower-door tests, we discuss the connection between airtightness and a successful decontamination ...
Airtightness in Belgian high biocontainment facilities
D/2016/2505/14 Accession Number: D/2016/2505/14 Keywords: airtightness biosafety BSL-3 Recommendations Abstract: Following a discussion in 2011 at the meeting of the European Joint Enforcement Group of Contained ...
Persistence of the protective immunity and kinetics of the isotype specific antibody response against the viral nucleocapsid protein after experimental Schmallenberg virus infection of sheep.
however not been studied in detail. Five sheep were kept in BSL3 facilities for more than 16 months and subjected to repeated SBV infections. Blood was regularly sampled and organs were collected at ...
In vitro surrogate models to aid in the development of antivirals for the containment of foot-and-mouth disease outbreaks.
ERAV surrogate models reported here can be manipulated in BSL-2 laboratories and may facilitate studies to unravel the mechanism of action of novel FMDV inhibitors. Health Topics: Animal health ...
Biosafety risk assessment and management of laboratory-derived influenza A (H5N1) viruses transmissible in ferrets
in the context of the European Union regulatory framework and recommend that laboratory-derived HPAI A (H5N1) viruses transmissible in ferrets should be handled in biosafety level 3 (BSL-3) facilities ...
Biosafety recommendations for the contained use of Mycobacterium tuberculosis complex isolates in industrialized countries
analysis AS Belgium biosafety BSL-3 classification Clinical containment Countries culture developed countries Diagnosis disease Diseases Dna Group Human identification incidence INFECTION Infectious ...
Biosafety risk assessment of the Severe Acute Respiratory Syndrome (SARS) coronavirus and containment measures for the diagnostic and research laboratories
performed under Biosafety Level 2 (BSL-2) conditions. Diagnostic activities involving non-inactivated clinical specimens associated with SARS should be carried out under BSL-2 containment with BSL-3 safety ...